| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.29 | 1e-13 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.21 | 6e-08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-07 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.28 | 1e-06 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.28 | 6e-06 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.19 | 1e-05 |